Intrathoracic amyloid tumors that presented as yellowish multinodular endobronchial protrusions with irregular vascularity and easy bleeding

por Tomono, Hiromi, Soda, Hiroshi, Fukuda, Yuichi, Tanaka, Yasuhiro, Ono, Sawana, Shimada, Midori, Iwasaki, Keisuke, Hisanaga, Masashi, Yamaguchi, Hiroyuki, Mukae, Hiroshi
Publicado 2019

Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma

por Umeyama, Yasuhiro, Taniguchi, Hirokazu, Gyotoku, Hiroshi, Senju, Hiroaki, Tomono, Hiromi, Takemoto, Shinnosuke, Yamaguchi, Hiroyuki, Tagod, Mohammed S. O., Iwasaki, Masashi, Tanaka, Yoshimasa, Mukae, Hiroshi
Publicado 2023

Dynamics of blood neutrophil‐related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non‐small cell lung cancer: A hypothesis‐generat...

por Soda, Hiroshi, Ogawara, Daiki, Fukuda, Yuichi, Tomono, Hiromi, Okuno, Daisuke, Koga, Seiko, Taniguchi, Hirokazu, Yoshida, Masataka, Harada, Tatsuhiko, Umemura, Asuka, Yamaguchi, Hiroyuki, Mukae, Hiroshi
Publicado 2018

Vildagliptin‐induced ground‐glass nodules mimicking lung metastases in a cancer patient receiving Lactobacillus probiotic supplementation

por Tanaka, Yasuhiro, Soda, Hiroshi, Fukuda, Yuichi, Nio, Kenta, Ono, Sawana, Tomono, Hiromi, Shimada, Midori, Yoshida, Masataka, Harada, Tatsuhiko, Umemura, Asuka, Iwasaki, Keisuke, Yamaguchi, Hiroyuki, Mukae, Hiroshi
Publicado 2020

Presence of few PD‐1‐expressing tumor‐infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non‐small cell lung ca...

por Ogawara, Daiki, Soda, Hiroshi, Tomono, Hiromi, Iwasaki, Keisuke, Hara, Takuya, Jinnai, Saeko, Funayama, Takatomo, Okuno, Daisuke, Taniguchi, Hirokazu, Yoshida, Masataka, Harada, Tatsuhiko, Umemura, Asuka, Fukuda, Yuichi, Yamaguchi, Hiroyuki, Mukae, Hiroshi
Publicado 2018

Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study

por Ikeda, Takaya, Takemoto, Shinnosuke, Senju, Hiroaki, Gyotoku, Hiroshi, Taniguchi, Hirokazu, Shimada, Midori, Dotsu, Yosuke, Umeyama, Yasuhiro, Tomono, Hiromi, Kitazaki, Takeshi, Fukuda, Masaaki, Soda, Hiroshi, Yamaguchi, Hiroyuki, Fukuda, Minoru, Mukae, Hiroshi
Publicado 2020

Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis

por Takemoto, Shinnosuke, Akagi, Kazumasa, Ono, Sawana, Tomono, Hiromi, Honda, Noritaka, Suyama, Takayuki, Umeyama, Yasuhiro, Dotsu, Yosuke, Taniguchi, Hirokazu, Ogawara, Daiki, Senju, Hiroaki, Gyotoku, Hiroshi, Sugasaki, Nanae, Yamaguchi, Hiroyuki, Nakatomi, Katsumi, Fukuda, Minoru, Mukae, Hiroshi
Publicado 2021

Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study

por Takemoto, Shinnosuke, Fukuda, Minoru, Yamaguchi, Hiroyuki, Ikeda, Takaya, Akagi, Kazumasa, Tomono, Hiromi, Umeyama, Yasuhiro, Dotsu, Yosuke, Taniguchi, Hirokazu, Gyotoku, Hiroshi, Senju, Hiroaki, Kitazaki, Takeshi, Nakatomi, Katsumi, Nagashima, Seiji, Fukuda, Masaaki, Kinoshita, Akitoshi, Soda, Hiroshi, Mukae, Hiroshi
Publicado 2019

Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib

por Yamaguchi, Ou, Kasahara, Norimitsu, Soda, Hiroshi, Imai, Hisao, Naruse, Ichiro, Yamaguchi, Hiroyuki, Itai, Miki, Taguchi, Kohei, Uchida, Megumi, Sunaga, Noriaki, Maeno, Toshitaka, Minato, Koichi, Tomono, Hiromi, Ogawara, Daiki, Mukae, Hiroshi, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Kagamu, Hiroshi, Kaira, Kyoichi
Publicado 2023

Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulati...

por Dotsu, Yosuke, Yamaguchi, Hiroyuki, Fukuda, Minoru, Suyama, Takayuki, Honda, Noritaka, Umeyama, Yasuhiro, Taniguchi, Hirokazu, Gyotoku, Hiroshi, Takemoto, Shinnosuke, Tagawa, Ryuta, Ogata, Ryosuke, Tomono, Hiromi, Shimada, Midori, Senju, Hiroaki, Nakatomi, Katsumi, Nagashima, Seiji, Soda, Hiroshi, Ikeda, Hiroaki, Ashizawa, Kazuto, Mukae, Hiroshi
Publicado 2021

Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study

por Tomono, Hiromi, Taniguchi, Hirokazu, Fukuda, Minoru, Ikeda, Takaya, Nagashima, Seiji, Akagi, Kazumasa, Ono, Sawana, Umeyama, Yasuhiro, Shimada, Midori, Gyotoku, Hiroshi, Takemoto, Shinnosuke, Hisamatsu, Yasushi, Morinaga, Ryotaro, Tagawa, Ryuta, Ogata, Ryosuke, Dotsu, Yosuke, Senju, Hiroaki, Soda, Hiroshi, Nakatomi, Katsumi, Hayashi, Fumiko, Sugasaki, Nanae, Kinoshita, Akitoshi, Mukae, Hiroshi
Publicado 2023

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study

por Akagi, Kazumasa, Taniguchi, Hirokazu, Fukuda, Minoru, Yamazaki, Takuya, Ono, Sawana, Tomono, Hiromi, Suyama, Takayuki, Shimada, Midori, Gyotoku, Hiroshi, Takemoto, Shinnosuke, Yamaguchi, Hiroyuki, Dotsu, Yosuke, Senju, Hiroaki, Soda, Hiroshi, Mizowaki, Takashi, Monzen, Yoshio, Ikeda, Takaya, Nagashima, Seiji, Tasaki, Yutaro, Nakamura, Daisuke, Komiya, Kazutoshi, Nakatomi, Katsumi, Sasaki, Eisuke, Hirakawa, Koichi, Mukae, Hiroshi
Publicado 2022